Health
STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies
Rare disease advocates applauded the FDA's move to speed access to treatments.
- Published
- (1 h ago)
- Outlet
- STAT News
- Section
- Health
- Length here
- Headline and 12-word snippet. The full article is at the source.
More from STAT News and around the same time
STAT+: RFK Jr. goes for broke in IowaKennedy on the campaign trail for MAHA, and new rules loom for U.S. investments in Chinese biotech.STAT+: Nonprofit resurrects shelved gene therapy after startup shuts downLast year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and moreA U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugsA possible treatment for brain-eating amoebas, found in the seaBrain-eating amoebas are hard to treat and nearly always fatal. But researchers have isolated a compound that could help stop the disease.Opinion: Cancer vaccines are finally here. How do we get them to patients?“If we want cancer vaccines to reach patients faster than BRCA testing did, there are several challenges to address now,” write Karen E. Knudsen and Othman Laraki.Opinion: Emergency pediatric care is now in permanent crisis mode“In 2026, the unprecedented pediatric patient crowding of 2022 has become a normal Tuesday,” write Jonathan Kohler and Mary King.This page holds the headline and a short snippet as published by STAT News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
